Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2022)
Niagen Bioscience (NAGE) posted quarterly Interest Coverage Ratio of 3.74 for Q1 2026, up 216.14% year-over-year from 1.18 in Q1 2025, and up 158.27% quarter-over-quarter from 6.42 in Q4 2025.
Powered by 
Analysis
Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2022) Analysis & Trends
Niagen Bioscience (NAGE) has reported Interest Coverage Ratio for 17 consecutive years, with 3.74 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 216.14% year-over-year to 3.74; the TTM figure through Mar 2026 stood at 31.08 (up 846.68% YoY), while the FY2025 annual figure was 0.4, up 130.47% from the prior year.
- Interest Coverage Ratio improved to 3.74 in Q1 2026 per NAGE's latest filing, from 6.42 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 29.38 in Q4 2024 and bottomed at 15.53 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 0.13 across 5 years, with a median of 0.52 in 2023.
- On a YoY basis, Interest Coverage Ratio climbed as much as 1884.05% in 2024 and fell as far as 256.16% in 2024.
- Niagen Bioscience's Interest Coverage Ratio stood at 10.7 in 2022, then jumped by 84.6% to 1.65 in 2023, then jumped by 1884.05% to 29.38 in 2024, then slumped by 121.86% to 6.42 in 2025, then jumped by 158.27% to 3.74 in 2026.
- Business Quant data shows NAGE's Interest Coverage Ratio at 3.74 in Q1 2026, 6.42 in Q4 2025, and 6.45 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -613.00 |
| Jun 30, 2022 | -638.70 |
| Mar 31, 2022 | -966.50 |
| Dec 31, 2021 | -590.67 |
| Sep 30, 2021 | -589.40 |
| Jun 30, 2021 | -462.83 |
| Mar 31, 2021 | -387.47 |
| Dec 31, 2020 | -380.06 |
| Sep 30, 2020 | -220.84 |
| Jun 30, 2020 | -153.63 |
| Dec 31, 2019 | 1,265.71 |
| Sep 30, 2019 | -21.94 |
| Jun 30, 2019 | -12.49 |
| Dec 31, 2018 | 374.55 |
| Sep 30, 2018 | -955.11 |
| Jun 30, 2018 | -122.11 |
| Mar 31, 2018 | -190.89 |
| Sep 30, 2017 | -70.58 |
| Jul 1, 2017 | -3.55 |
| Apr 1, 2017 | -63.32 |